These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 8955363

  • 1. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2.
    Lichte A, Kolkenbrock H, Tschesche H.
    FEBS Lett; 1996 Nov 18; 397(2-3):277-82. PubMed ID: 8955363
    [Abstract] [Full Text] [Related]

  • 2. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H, Atkinson SJ, Butler GS, Smith B, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17119-23. PubMed ID: 8663332
    [Abstract] [Full Text] [Related]

  • 3. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
    Butler GS, Will H, Atkinson SJ, Murphy G.
    Eur J Biochem; 1997 Mar 01; 244(2):653-7. PubMed ID: 9119036
    [Abstract] [Full Text] [Related]

  • 4. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H.
    Biol Chem; 1997 Feb 01; 378(2):71-6. PubMed ID: 9088534
    [Abstract] [Full Text] [Related]

  • 5. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 6. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 7. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.
    Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M.
    FEBS Lett; 1996 Sep 09; 393(1):101-4. PubMed ID: 8804434
    [Abstract] [Full Text] [Related]

  • 8. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2.
    Bigg HF, Shi YE, Liu YE, Steffensen B, Overall CM.
    J Biol Chem; 1997 Jun 13; 272(24):15496-500. PubMed ID: 9182583
    [Abstract] [Full Text] [Related]

  • 9. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 10. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.
    EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659
    [Abstract] [Full Text] [Related]

  • 11. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses.
    Fujimoto N, Ward RV, Shinya T, Iwata K, Yamashita K, Hayakawa T.
    Biochem J; 1996 Feb 01; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162
    [Abstract] [Full Text] [Related]

  • 12. Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation.
    Overall CM, Tam E, McQuibban GA, Morrison C, Wallon UM, Bigg HF, King AE, Roberts CR.
    J Biol Chem; 2000 Dec 15; 275(50):39497-506. PubMed ID: 10991943
    [Abstract] [Full Text] [Related]

  • 13. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.
    Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Schade van Westrum S, Crabbe T, Clements J, d'Ortho MP, Murphy G.
    J Biol Chem; 1998 Jan 09; 273(2):871-80. PubMed ID: 9422744
    [Abstract] [Full Text] [Related]

  • 14. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A.
    Cao J, Drews M, Lee HM, Conner C, Bahou WF, Zucker S.
    J Biol Chem; 1998 Dec 25; 273(52):34745-52. PubMed ID: 9856998
    [Abstract] [Full Text] [Related]

  • 15. Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.
    Lafleur MA, Tester AM, Thompson EW.
    FEBS Lett; 2003 Oct 23; 553(3):457-63. PubMed ID: 14572669
    [Abstract] [Full Text] [Related]

  • 16. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads.
    Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M.
    J Biol Chem; 1998 Jun 26; 273(26):16098-103. PubMed ID: 9632662
    [Abstract] [Full Text] [Related]

  • 17. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts.
    Ward RV, Atkinson SJ, Reynolds JJ, Murphy G.
    Biochem J; 1994 Nov 15; 304 ( Pt 1)(Pt 1):263-9. PubMed ID: 7998943
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases.
    English WR, Holtz B, Vogt G, Knäuper V, Murphy G.
    J Biol Chem; 2001 Nov 09; 276(45):42018-26. PubMed ID: 11555661
    [Abstract] [Full Text] [Related]

  • 19. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
    Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R.
    J Biol Chem; 2000 Apr 21; 275(16):12080-9. PubMed ID: 10766841
    [Abstract] [Full Text] [Related]

  • 20. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M.
    EMBO J; 2001 Sep 03; 20(17):4782-93. PubMed ID: 11532942
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.